These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats. Lepola VT, Kippo K, Hannuniemi R, Laurén L, Virtamo T, Osterman T, Jalovaara P, Sellman R, Väänänen HK. J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851 [Abstract] [Full Text] [Related]
11. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M. Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709 [Abstract] [Full Text] [Related]
12. Effect of raloxifene on arthritis and bone mineral density in rats with collagen-induced arthritis. Hayashi I, Hagino H, Okano T, Enokida M, Teshima R. Calcif Tissue Int; 2011 Feb; 88(2):87-95. PubMed ID: 21140260 [Abstract] [Full Text] [Related]
14. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY. Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [Abstract] [Full Text] [Related]
15. Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats. Tasci AG, Bilgili H, Altunay H, Gecit MR, Keskin D. Eur J Pharm Sci; 2011 Jul 17; 43(4):270-7. PubMed ID: 21575717 [Abstract] [Full Text] [Related]
16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K. Bone; 2008 Nov 17; 43(5):894-900. PubMed ID: 18687415 [Abstract] [Full Text] [Related]
17. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. Otomo H, Sakai A, Ikeda S, Tanaka S, Ito M, Phipps RJ, Nakamura T. J Bone Miner Metab; 2004 Nov 17; 22(5):404-14. PubMed ID: 15316861 [Abstract] [Full Text] [Related]
18. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats. Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR. Calcif Tissue Int; 2003 Apr 17; 72(4):519-27. PubMed ID: 12574877 [Abstract] [Full Text] [Related]
19. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats. Sato M, Bryant HU, Iversen P, Helterbrand J, Smietana F, Bemis K, Higgs R, Turner CH, Owan I, Takano Y, Burr DB. J Pharmacol Exp Ther; 1996 Oct 17; 279(1):298-305. PubMed ID: 8859007 [Abstract] [Full Text] [Related]
20. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Uyar Y, Baytur Y, Inceboz U, Demir BC, Gumuser G, Ozbilgin K. Maturitas; 2009 Jul 20; 63(3):261-7. PubMed ID: 19386450 [Abstract] [Full Text] [Related] Page: [Next] [New Search]